Cellosaurus logo
expasy logo

Cellosaurus CHLA-172 (CVCL_A056)

[Text version]
Cell line name CHLA-172
Accession CVCL_A056
Resource Identification Initiative To cite this cell line use: CHLA-172 (RRID:CVCL_A056)
Sequence variations
Disease Neuroblastoma (NCIt: C3270)
Neuroblastoma (ORDO: Orphanet_635)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Male
Age at sampling Children
Category Cancer cell line
STR profile Source(s): COG

Markers:
AmelogeninX,Y
CSF1PO10,13
D2S133818,28
D3S135815
D5S81811
D7S82010,11
D8S117912,14
D13S31712,13
D16S5399
D18S5114,17
D19S43314.2,15
D21S1130,31
FGA18,24
TH016
TPOX8,11
vWA17

Run an STR similarity search on this cell line
Publications

PubMed=11507071
Keshelava N., Zuo J.J., Chen P., Waidyaratne S.N., Luna M.C., Gomer C.J., Triche T.J., Reynolds C.P.
Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines.
Cancer Res. 61:6185-6193(2001)

PubMed=24792489; DOI=10.1007/s11060-014-1456-8
Farooqi A.S., Dagg R.A., Choi L.M.R., Shay J.W., Reynolds C.P., Lau L.M.S.
Alternative lengthening of telomeres in neuroblastoma cell lines is associated with a lack of MYCN genomic amplification and with p53 pathway aberrations.
J. Neurooncol. 119:17-26(2014)

Cross-references
Cell line databases/resources cancercelllines; CVCL_A056
Encyclopedic resources Wikidata; Q54812172
Polymorphism and mutation databases IARC_TP53; 16200
Entry history
Entry creation06-Jun-2012
Last entry update19-Dec-2024
Version number16